Estimation of sensitivity and specificity of several Trypanosoma cruzi antibody assays in blood donors in Argentina

Transfusion

Volumn 49, Issue 11, 2009, Pages 2352-2358

  Remesar, Mirta C ^a   Gamba, Cecilia ^a   Colaianni, Ivana F ^a   Puppo, Mónica ^a   Sartor, Paula A ^a   Murphy, Edward L ^a   Neilands, Torsten B ^a   Ridolfi, María A ^a   Leguizamón, M Susana ^a   Kuperman, Silvina ^a   Del Pozo, Ana E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGENTINA; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; CHAGAS DISEASE; DIAGNOSTIC KIT; ENZYME IMMUNOASSAY; HUMAN; INDIRECT HEMAGGLUTINATION ASSAY; MAJOR CLINICAL STUDY; PARTICLE AGGLUTINATION ASSAY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TRANS SIALIDASE INHIBITION ASSAY; TRYPANOSOMA CRUZI;

ANTIBODIES, PROTOZOAN; ARGENTINA; BIOLOGICAL ASSAY; BLOOD DONORS; CHAGAS DISEASE; GLYCOPROTEINS; HEMAGGLUTINATION TESTS; HUMANS; IMMUNOENZYME TECHNIQUES; NEURAMINIDASE; REPRODUCIBILITY OF RESULTS; TRYPANOSOMA CRUZI;

EID: 70449097984     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02301.x     Document Type: Article

References (32)

1. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 2003 98 : 577 91.
2. Gurtler RE, Kitron U, Cecere MC, Segura EL, Cohen JE. Sustainable vector control and management of Chagas disease in the Gran Chaco, Argentina. Proc Natl Acad Sci U S A 2007 104 : 16194 9.
3. Biancardi MA, Conca Moreno M, Torres N, Pepe C, Altcheh J, Freilij H Seroprevalence of Chagas disease in 17 rural communities of "Monte Impenetrable", Chaco Province Medicina (B Aires) 2003 63 : 125 9.
4. Centers for Disease Control and Prevention. Blood donor screening for chagas disease - United States, 2006-2007. MMWR Morb Mortal Wkly Rep 2007 56 : 141 3.
5. Leiby DA, Herron RM Jr., Read EJ, Lenes BA, Stumpf RJ. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 2002 42 : 549 55.
6. Tobler LH, Contestable P, Pitina L, Groth H, Shaffer S, Blackburn GR, Warren H, Lee SR, Busch MP. Evaluation of a new enzyme-linked immunosorbent assay for detection of Chagas antibody in US blood donors. Transfusion 2007 47 : 90 6.
7. Flores-Chavez M, Fernandez B, Puente S, Torres P, Rodriguez M, Monedero C, Cruz I, Garate T, Canavate C. Transfusional chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. Clin Infect Dis 2008 46 : e44 7.
8. Schijman AG, Vigliano C, Burgos J, Favaloro R, Perrone S, Laguens R, Levin MJ. Early diagnosis of recurrence of Trypanosoma cruzi infection by polymerase chain reaction after heart transplantation of a chronic Chagas' heart disease patient. J Heart Lung Transpl 2000 19 : 1114 7.
9. Solari A, Ortiz S, Soto A, Arancibia C, Campillay R, Contreras M, Salinas P, Rojas A, Schenone H. Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCR. J Antimicrob Chemother 2001 48 : 515 9.
10. Schijman AG, Altcheh J, Burgos JM, Biancardi M, Bisio M, Levin MJ, Freilij H. Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction. J Antimicrob Chemother 2003 52 : 441 9.
11. Umezawa ES, Bastos SF, Coura JR, Levin MJ, Gonzalez A, Rangel-Aldao R, Zingales B, Luquetti AO, da Silveira JF. An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens. Transfusion 2003 43 : 91 7.
12. da Silveira JF, Umezawa ES, Luquetti AO. Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis. Trends Parasitol 2001 17 : 286 91.
13. Leguizamon MS, Campetella O, Russomando G, Almiron M, Guillen I, Ganzalez Cappa SM, Frasch AC. Antibodies inhibiting Trypanosoma cruzi trans-sialidase activity in sera from human infections. J Infect Dis 1994 170 : 1570 4.
14. WHO. Control of Chagas disease: second report of the WHO expert committee. WHO Tech Rep Ser 2002 905 : 1 109.
15. WHO. Control of Chagas disease: report of a WHO expert committee. WHO Tech Rep Ser 1991 811 : 1 95.
16. Schmunis GA, Zicker F, Segura EL, del Pozo AE. Transfusion-transmitted infectious diseases in Argentina, 1995 through 1997. Transfusion 2000 40 : 1048 53.
17. Berrizbeitia M, Ndao M, Bubis J, Gottschalk M, Ache A, Lacouture S, Medina M, Ward BJ. Field evaluation of four novel enzyme immunoassays for Chagas' disease in Venezuela blood banks: comparison of assays using fixed-epimastigotes, fixed-trypomastigotes or trypomastigote excreted-secreted antigens from two Trypanosoma cruzi strains. Transfus Med 2006 16 : 419 31.
18. Caballero ZC, Sousa OE, Marques WP, Saez-Alquezar A, Umezawa ES. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp. Clin Vaccine Immunol 2007 14 : 1045 9.
19. Oelemann WM, Teixeira MD, Verissimo Da Costa GC, Borges-Pereira J, De Castro JA, Coura JR, Peralta JM. Evaluation of three commercial enzyme-linked immunosorbent assays for diagnosis of Chagas' disease. J Clin Microbiol 1998 36 : 2423 7.
20. Sanchez Negrette O, Mora MC, Basombrio MA. High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina. Pediatrics 2005 115 : 668 72.
21. Buschiazzo A, Frasch AC, Campetella O. Medium scale production and purification to homogeneity of a recombinant trans-sialidase from Trypanosoma cruzi. Cell Mol Biol (Noisy-le-grand) 1996 42 : 703 10.
22. Leguizamon MS, Russomando G, Luquetti A, Rassi A, Almiron M, Gonzalez-Cappa SM, Frasch AC, Campetella O. Long-lasting antibodies detected by a trans-sialidase inhibition assay of sera from parasite-free, serologically cured chagasic patients. J Infect Dis 1997 175 : 1272 5.
23. Leiby DA, Wendel S, Takaoka DT, Fachini RM, Oliveira LC, Tibbals MA. Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits. J Clin Microbiol 2000 38 : 639 42.
24. Moncayo A, Ortiz Yanine MI. An update on Chagas disease (human American trypanosomiasis). Ann Trop Med Parasitol 2006 100 : 663 77.
25. Gadelha AA, Vercosa AF, Lorena VM, Nakazawa M, Carvalho AB, Souza WV, Ferreira AG, Silva ED, Krieger MA, Goldenberg S, Gomes YM. Chagas' disease diagnosis: comparative analysis of recombinant ELISA with conventional ELISA and the haemagglutination test. Vox Sang 2003 85 : 165 70.
26. Buchovsky AS, Campetella O, Russomando G, Franco L, Oddone R, Candia N, Luquetti A, Gonzalez Cappa SM, Leguizamon MS. trans-sialidase inhibition assay, a highly sensitive and specific diagnostic test for Chagas' disease. Clin Diagn Lab Immunol 2001 8 : 187 9.
27. Uebersax JS, Grove WM. Latent class analysis of diagnostic agreement. Stat Med 1990 9 : 559 72.
28. Yang I, Becker MP. Latent variable modeling of diagnostic accuracy. Biometrics 1997 53 : 948 58.
29. Pirard M, Iihoshi N, Boelaert M, Basanta P, Lopez F, Van der Stuyft P. The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion 2005 45 : 554 61.
30. Pellett PE, Wright DJ, Engels EA, Ablashi DV, Dollard SC, Forghani B, Glynn SA, Goedert JJ, Jenkins FJ, Lee TH, Neipel F, Todd DS, Whitby D, Nemo GJ, Busch MP. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion 2003 43 : 1260 8.
31. Leguizamon MS, Russomando G, Rojas de Arias A, Samudio M, Cabral M, Gonzalez-Cappa SM, Frasch AC, Campetella O. Use of trans-Sialidase inhibition assay in a population serologically negative for Trypanosoma cruzi but at a high risk of infection. Clin Diagn Lab Immunol 1998 5 : 254 5.
32. Leiby DA, Herron RM Jr., Garratty G, Herwaldt BL. Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection. J Infect Dis 2008 198 : 609 13.